Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic and predictive significance of MSI in stages II/III colon cancer.

World journal of gastroenterology - 14 Jun 2014

Saridaki Zacharenia, Souglakos John, Georgoulias Vassilis

Abstract excerpt

In colon cancer, classic disease staging remains the key prognosis and treatment determinant. Although adjuvant chemotherapy has an established role in stage III colon cancer patients, in stage II it is still a subject of controversy due to its restriction to a small subgroup of patients with hig...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemotherapy, Adjuvant
Share to Colectomy
Share to Colonic Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Microsatellite Instability

Share to Neoplasm Staging

Share to Patient Selection

Share to Precision Medicine

Share to Predictive Value of Tests

Source

Open in PubMed Open full text

Identifiers

PMID: 24944470
DOI: 10.3748/wjg.v20.i22.6809
PMCID: PMC4051919

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24944470-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic and predictive significance of MSI in stages II/III colon cancer.PMID 24944470Read ↗

The prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancer.Semantic proximity Read ↗

Subgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy.Semantic proximity Read ↗

Determination of <i>TP53</i> Mutation Is More Relevant Than Microsatellite Instability Status for the Prediction of Disease-Free Survival in Adjuvant-Treated Stage III Colon Cancer PatientsSemantic proximity Read ↗

Genetic alterations in locally advanced stage II/III colon cancer: a search for prognostic markers.Semantic proximity Read ↗

Toward a Molecular Classification of Colorectal Cancer: The Role of Microsatellite Instability StatusSemantic proximity Read ↗

Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population‐based studySemantic proximity Read ↗

Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer.Semantic proximity Read ↗

Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study.Semantic proximity Read ↗

Prognostic and Predictive Cross-Roads of Microsatellite Instability and Immune Response to Colon CancerSemantic proximity Read ↗

Prognostic and clinicopathologic significance of BRAF mutation in colon cancer by MSI status and stage: A large cohort analysis.Semantic proximity Read ↗

Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.Semantic proximity Read ↗

Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.